HHS updates its national dementia plan, prioritizing risk reduction, early detection, biomarkers, and faster diagnostics and treatments through new FDA, CMS, and ARPA-H initiatives.
|Articles|April 24, 2013
Slideshow: Developmental Psychopathology Comes of Age
Listen
0:00 / 0:00
Key Takeaways
- Developmental psychopathology perspectives can refine differential diagnosis and longitudinal management strategies for mood disorders, ADHD, and psychotic presentations in general psychiatry.
- A streamlined slide set summarizes traumatic brain injury with emphasis on psychiatric sequelae, evaluation considerations, and implications for ongoing clinical monitoring.
Traumatic brain injury, criminal responsibility, traumatic stress, and autism spectrum/neurodevelopmental disorders slideshow
Advertisement
Child and adolescent psychiatry is in a position to inform the entire practice of general psychiatry in areas such as mood disorders, ADHD, and psychosis. This slideshow (
DSM-IV
DSM-5
• Autistic disorder, Asperger disorder, childhood disintegrative disorder, and pervasive developmental disorder NOS
• Autism spectrum disorder
• No equivalent DSM-IV diagnosis
• Social communication disorder
• Rett disorder
• Not included in DSM-5
• Mental retardation
• Intellectual disability
• Reading disorder
• Dyslexia
• Mathematics disorder
• Dyscalculia
• Disorder of written expression and learning disorder not otherwise specified
• Unspecified learning disorder
• Expressive language disorder
• Language impairment, late language emergence, or specific language impairment
• Mixed receptive-expressive language disorder
• No equivalent DSM-5 diagnosis
• Stuttering
• Childhood onset fluency disorder
Advertisement
Related to this article
Neflamapimod misses its main DLB endpoint, but biomarker and subgroup signals suggest IL-1β pathway impact and may justify a phase 3 trial.
Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
New automated connectomics maps synapses across circuits, revealing how inhibitory neuron subtypes shape decision-making and may explain circuit dysfunction in psychiatric disorders.
Sleep disruption fuels Alzheimer risk via apnea, fragmentation, and inflammation; improving consolidated sleep, medication review, and sleep-specialist teamwork may protect cognition.
Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.
Adjustment disorder often goes undiagnosed after major life stressors, especially in cancer care; learn updated criteria, risks, and emerging therapies like psilocybin.
APSARD is preparing US adult ADHD guidelines, delivering long-awaited screening, diagnosis, and treatment recommendations as experts discuss the upcoming release.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Burnout, Gratitude, and the Value of Staying Current: On the Mind of Gus Alva, MD, DFAPA
2
Daridorexant, Orexin Receptor Agonist, Shows Positive Results in Pediatric Insomnia
3
Dementia Pipeline Update: Phase 2 and 3 Developments in Alzheimer Disease and Lewy Body Dementia
4
Food Noise and GLP-1 Drugs: What Research Reveals About Motivation and Appetitive Drive
5